Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

New data confirm long-term durability of Resilia tissue | CCTA delivers clarity, better outcomes | Cannabis use & heart attacks

News You Need to Know Today
New data confirm long-term durability of Resilia tissue | CCTA delivers clarity, better outcomes | Cannabis use & heart attacks
Thursday, May 7, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

READ MORE >
Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026
Share on Twitter Share on Facebook Share on Linkedin

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Share on Twitter Share on Facebook Share on Linkedin
Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026
Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.
READ MORE >

CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

READ MORE >
CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.
Share on Twitter Share on Facebook Share on Linkedin

CCTA brings clarity, better outcomes to CTO PCI

Share on Twitter Share on Facebook Share on Linkedin
CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.
Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.
READ MORE >

Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

READ MORE >
Emergency Department room ED ER EM
Share on Twitter Share on Facebook Share on Linkedin

Cannabis use increases risk of death, heart attack for ED patients

Share on Twitter Share on Facebook Share on Linkedin
Emergency Department room ED ER EM
When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.
READ MORE >

Featured Articles

SCCT President: Key trends in cardiac CT

As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.

READ MORE >
Society of cardiovascular computed tomography (SCCT) President Kavitha Chinnaiyan, MD, FACC, MSCCT, a cardiologist and professor of medicine at Oakland University William Beaumont School of Medicine in Royal Oak, with is part of Corewell Health, explains some of the key trends in coronary computed tomography angiography (CCTA) and how this is being translated into educational programming at the SCCT 2026 annual scientific meeting (ASM). #SCCT2026
Share on Twitter Share on Facebook Share on Linkedin

SCCT President: Key trends in cardiac CT

Share on Twitter Share on Facebook Share on Linkedin
Society of cardiovascular computed tomography (SCCT) President Kavitha Chinnaiyan, MD, FACC, MSCCT, a cardiologist and professor of medicine at Oakland University William Beaumont School of Medicine in Royal Oak, with is part of Corewell Health, explains some of the key trends in coronary computed tomography angiography (CCTA) and how this is being translated into educational programming at the SCCT 2026 annual scientific meeting (ASM). #SCCT2026
As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.
READ MORE >

Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients

New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy. 

READ MORE >
Model in the Abiomed booth showing placement of the Impella 5.5 liters per minute catheter heart pump. This is used for patients who need more support than a conventional Impella CP can offer, but does not require level of supported from ECMO.
Share on Twitter Share on Facebook Share on Linkedin

Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients

Share on Twitter Share on Facebook Share on Linkedin
Model in the Abiomed booth showing placement of the Impella 5.5 liters per minute catheter heart pump. This is used for patients who need more support than a conventional Impella CP can offer, but does not require level of supported from ECMO.
New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy. 
READ MORE >

TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision

When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.
READ MORE >

First patient enrolled in massive heart failure trial

Data from BENEFIT-HF, a new randomized study of CVRx's implantable Barostim device, could open up access to many more heart failure patients. 

READ MORE >
CVRx banner
Share on Twitter Share on Facebook Share on Linkedin

First patient enrolled in massive heart failure trial

Share on Twitter Share on Facebook Share on Linkedin
CVRx banner
Data from BENEFIT-HF, a new randomized study of CVRx's implantable Barostim device, could open up access to many more heart failure patients. 
READ MORE >

In Case You Missed It

Long-term antidepressant use may increase risk of sudden cardiac death

The risk appears to be greatest when patients are still actively taking antidepressants. Researchers noted that many more studies on this topic are still necessary.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Long-term antidepressant use may increase risk of sudden cardiac death

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
The risk appears to be greatest when patients are still actively taking antidepressants. Researchers noted that many more studies on this topic are still necessary.
READ MORE >

Stereotaxis to acquire robotic PCI company Robocath for up to $45M

The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.

READ MORE >
Robocath acquired by Stereotaxis
Share on Twitter Share on Facebook Share on Linkedin

Stereotaxis to acquire robotic PCI company Robocath for up to $45M

Share on Twitter Share on Facebook Share on Linkedin
Robocath acquired by Stereotaxis
The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.
READ MORE >

FDA links weight loss pill to ‘unexpected’ cardiovascular risks

The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects. 

READ MORE >
overweight patient seeking health advice
Share on Twitter Share on Facebook Share on Linkedin

FDA links weight loss pill to ‘unexpected’ cardiovascular risks

Share on Twitter Share on Facebook Share on Linkedin
overweight patient seeking health advice
The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects. 
READ MORE >

In Other News

UnitedHealthcare looks to reduce prior authorizations by 30% before end of 2026

The insurance arm of UnitedHealth Group said the shift is part of its ongoing effort to eliminate the barriers between care delivery and medical coverage. The full list of services exempt from prior authorizations includes diagnostic tests and many outpatient surgeries.

READ MORE >
UnitedHealth Group - 2
Share on Twitter Share on Facebook Share on Linkedin

UnitedHealthcare looks to reduce prior authorizations by 30% before end of 2026

Share on Twitter Share on Facebook Share on Linkedin
UnitedHealth Group - 2
The insurance arm of UnitedHealth Group said the shift is part of its ongoing effort to eliminate the barriers between care delivery and medical coverage. The full list of services exempt from prior authorizations includes diagnostic tests and many outpatient surgeries.
READ MORE >

5-year checkup shows ‘hospital at home’ healthy but siloed

Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for reasonable overall costs. In fact “HaH” is sometimes considerably better on both those scores.

READ MORE >
homecare hospital at home
Share on Twitter Share on Facebook Share on Linkedin

5-year checkup shows ‘hospital at home’ healthy but siloed

Share on Twitter Share on Facebook Share on Linkedin
homecare hospital at home
Hospital-at-home inpatient care is no worse than its traditional counterpart at facilitating good clinical outcomes for reasonable overall costs. In fact “HaH” is sometimes considerably better on both those scores.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout
FDA clears first surgical valve of its kind | Family files $17M lawsuit | BATMAN to the rescue | Major trends at SCCT 2026

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup